ORGANIGRAM GLOBAL INC. (OGI) research

ORGANIGRAM GLOBAL INC.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Last price
$1.05
As of

ORGANIGRAM GLOBAL INC. (OGI): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-03.

As of . Source: SEC EDGAR filings for OGI. Method and limitations.

SHARE THIS CARD

Share the OGI intelligence card

A branded snapshot of OGI: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion OGI intelligence card preview
Post to X
LIVE TERMINAL

See OGI live in the terminal

Track OGI's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live OGI terminal, free

Active signals for OGI

FREE, NO ACCOUNT

Every signal on OGI, as it fires

You are seeing 5 of 23 signals recorded on OGI since 2026-06-03.

The five above landed across 2 days. The other 18 were recorded on 5 other days. 16 of the 23 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in OGI (2026Q2)

Manager / securityMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLCCUSIP 68617J100 · 2026Q2$1.5M0.00%,
CITADEL ADVISORS LLCCUSIP 68617J100 · 2026Q2$75K0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 68617J100 · 2026Q2$37K0.00%,
MILLENNIUM MANAGEMENT LLCCUSIP 68617J100 · 2026Q2$18K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, OGI

OGI mentioned in Kresmion daily briefs

OGI against its peers

OGI's return on equity of -14.9% ranks in the 58th percentile of 5 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2024-09-30 and 2024-12-31.

MetricOGIPeer medianPercentilen
Revenue FY160M CADn/an/a0
Gross margin29.7%n/an/a4
Operating margin-22.3%n/an/a4
Net margin-28.4%n/an/a4
Return on equity-14.9%-15.7%585

Peers (6): CRDL, BGM, CRLBF, INCR, ZYBT, NIKA. Left out: LFCR (no annual filing), ASRT (no annual filing), ADCT (period gap), DERM (period gap), TSNDF (period gap), CPIX (period gap), PHBI (period gap), CTOR (no annual filing), GRUSF (period gap), AAWH (period gap), AKBA (period gap), ELTP (period gap), CWBHF (period gap), JUSHF (period gap), BORAY (no annual filing), CGC (period gap), TLPH (period gap), VRNO (period gap), TKNO (period gap). Fiscal periods ending between 2024-09-30 and 2024-12-31. Every figure is one full fiscal year read from one annual filing (OGI: 40-F), reported in CAD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more OGI signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to OGIand get the insider, 13F, options, and confluence read in one view.

Open the live OGI terminal, free